κ-opioid receptor - Wikipedia
Study provides clues for designing new anti-addiction medications | National Institutes of Health (NIH)
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Opioid agonists, mixed agonist-antagonists and partial agonists | Osmosis
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
κ-opioid receptor - Wikipedia
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat | Request PDF
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Selective kappa opioid antagonists for treatment of addiction, are we there yet? - ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Opioids - Pharmacology Flashcards | Draw it to Know it
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
Current status of opioid addiction treatment and related preclinical research | Science Advances
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Focusing on the Opioid System for Addiction Biomarker Discovery: Trends in Molecular Medicine
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
